Case number: 1:23-bk-10113 - Acerus Labs Inc. and Acerus Pharmaceuticals Corporation - Delaware Bankruptcy Court

Case Information
  • Case title

    Acerus Labs Inc. and Acerus Pharmaceuticals Corporation

  • Court

    Delaware (debke)

  • Chapter

    15

  • Judge

    Mary F. Walrath

  • Filed

    01/29/2023

  • Last Filing

    08/31/2023

  • Asset

    No

  • Vol

    v

Docket Header
JNTADMN



U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 23-10113-MFW

Assigned to: Mary F. Walrath
Chapter 15
Voluntary


Date filed:  01/29/2023

Debtor

Acerus Labs Inc.

205-7025 Langer Drive
Mississauga
Ontario L5L 1J9
OUTSIDE U. S.
Canada
Tax ID / EIN: 00-0000000

represented by
Michael Jason Barrie

Benesch Friedlander Coplan & Aronoff LLP
1313 North Market Street
Suite 1201
Wilmington, DE 19801
(302) 442-7010
Fax : (302) 442-7012
Email: mbarrie@beneschlaw.com

Jennifer R. Hoover

Benesch Friedlander Coplan & Aronoff LLP
1313 North Market Street
Suite 1201
Wilmington, DE 19801
302-442-7010
Fax : 302-442-7012
Email: jhoover@beneschlaw.com

Steven Walsh

Benesch Friedlander Coplan & Aronoff LLP
1313 North Market Street
Suite 1201
Wilmington, DE 19801
302-442-7059
Email: SWalsh@beneschlaw.com

Foreign Representative

Acerus Pharmaceuticals Corporation

205-7025 Langer Drive
Mississauga
Ontario L5L 1J9
OUTSIDE U. S.
Canada
Tax ID / EIN: 98-1229465

represented by
Michael J. Barrie

Benesch, Friedlander, Coplan & Aronoff
1313 North Market Street
Suite 1201
Wilmington, DE 19801
302-442-7010
Fax : 302-442-7012
Email: mbarrie@beneschlaw.com

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491
 
 

Latest Dockets

Date Filed#Docket Text
01/31/20234Order Directing Joint Administration of Chapter 15 Cases and Granting Related Relief. An order has been entered in this case directing the joint administration of the chapter 15 cases of Acerus Pharmaceuticals Corporation (6891); Acerus Biopharma Inc. (0687); Acerus Labs Inc. (0126); and Acerus Pharmaceuticals USA, LLC (9089). All further pleadings and papers shall be filed, and all further docket entries shall be made, in Case No. 23-10111 (MFW), and such docket should be consulted for all matters affecting these chapter 15 cases. (related document(s) 3). Signed on 1/31/2023. (LMC) (Entered: 01/31/2023)
01/30/2023Judge Mary F. Walrath added to case (SJS) (Entered: 01/30/2023)
01/29/20233Motion for Joint Administration Filed by Acerus Pharmaceuticals Corporation. (Hoover, Jennifer) (Entered: 01/29/2023)
01/29/2023Attorney Jennifer R. Hoover and Michael Jason Barrie for Acerus Labs Inc., Steven Walsh and Michael Jason Barrie for Acerus Labs Inc. added to case Filed by Acerus Labs Inc.. (Barrie, Michael) (Entered: 01/29/2023)
01/29/20232Receipt of filing fee for Petition Foreign Proceeding (Chapter 15)( 23-10113) [misc,volpfp15] (1738.00). Receipt Number A10977268, amount $1738.00. (U.S. Treasury) (Entered: 01/29/2023)
01/29/20231Chapter 15 Petition for Recognition of Foreign Proceeding. Fee Amount $1738 Filed by Acerus Labs Inc., Michael Jason Barrie. (Barrie, Michael) (Entered: 01/29/2023)